Authors:
Harkany, T
O'Mahony, S
Keijser, J
Kelly, JP
Konya, C
Borostyankoi, ZA
Gorcs, TJ
Zarandi, M
Penke, B
Leonard, BE
Luiten, PGM
Citation: T. Harkany et al., beta-amyloid((1-42))-induced cholinergic lesions in rat nucleus basalis bidirectionally modulate serotonergic innervation of the basal forebrain and cerebral cortex, NEUROBIOL D, 8(4), 2001, pp. 667-678
Authors:
Ryan, PM
Kelly, JP
Chambers, PL
Leonard, BE
Citation: Pm. Ryan et al., The toxicity profile of a single dose of paroxetine: An alternative approach to acute toxicity testing in the rat, PHARM TOX, 88(2), 2001, pp. 59-66
Authors:
Filley, CM
Price, BH
Nell, V
Antoinette, T
Morgan, AS
Bresnahan, JF
Pincus, JH
Gelbort, MM
Weissberg, M
Kelly, JP
Citation: Cm. Filley et al., Toward an understanding of violence: Neurobehavioral aspects of unwarranted physical aggression: Aspen Neurobehavioral Conference consensus statement, NEUROPS NEU, 14(1), 2001, pp. 1-14
Citation: Dw. Kaufman et Jp. Kelly, Acetylsalicylic acid and other salicylates in relation to Stevens-Johnson syndrome and toxic epidermal necrolysis, BR J CL PH, 51(2), 2001, pp. 174-176
Authors:
O'Loinsigh, ED
Boland, G
Kelly, JP
O'Boyle, KM
Citation: Ed. O'Loinsigh et al., Behavioural, hyperthermic and neurotoxic effects of 3,4-methylenedioxymethamphetamine analogues in the Wistar rat, PROG NEUR-P, 25(3), 2001, pp. 621-638
Citation: Tj. Connor et al., Methylenedioxymethamphetamine (MDMA; 'Ecstasy') suppresses antigen specific IgG(2a) and IFN-gamma production, IMMUNOL LET, 78(2), 2001, pp. 67-73
Authors:
Harkin, A
Connor, TJ
Mulrooney, J
Kelly, JP
Leonard, BE
Citation: A. Harkin et al., Prior exposure to methylenedioxyamphetamine (MDA) induces serotonergic loss and changes in spontaneous exploratory and amphetamine-induced behaviors in rats, LIFE SCI, 68(12), 2001, pp. 1367-1382
Authors:
Connor, TJ
Dennedy, MC
Harkin, A
Kelly, JP
Citation: Tj. Connor et al., Methylenedioxymethamphetamine-induced suppression of interleukin-1 beta and tumour necrosis factor-alpha is not mediated by serotonin, EUR J PHARM, 418(1-2), 2001, pp. 147-152
Authors:
Connor, TJ
Harkin, A
Kelly, JP
Leonard, BE
Citation: Tj. Connor et al., Olfactory bulbectomy provokes a suppression of interleukin-1 beta and tumour necrosis factor-alpha production in response to an in vivo challenge with lipopolysaccharide: Effect of chronic desipramine treatment, NEUROIMMUNO, 7(1), 2000, pp. 27-35
Authors:
Nolan, Y
Connor, TJ
Kelly, JP
Leonard, BE
Citation: Y. Nolan et al., Lipopolysaccharide administration produces time-dependent and region-specific alterations in tryptophan and tyrosine hydroxylase activities in rat brain, J NEURAL TR, 107(12), 2000, pp. 1393-1401
Citation: A. Harkin et al., Effects of reboxetine and sertraline treatments alone and in combination on the binding properties of cortical NMDA and beta 1-adrenergic receptors in an animal model of depression, J NEURAL TR, 107(10), 2000, pp. 1213-1227
Citation: Tj. Conner et al., An assessment of the acute effects of the serotonin releasers methylenedioxymethamphetamine, methylenedioxyamphetamine and fenfluramine on immunity in rats, IMMUNOPHARM, 46(3), 2000, pp. 223-235
Authors:
Connor, TJ
Kelliher, P
Shen, Y
Harkin, A
Kelly, JP
Leonard, BE
Citation: Tj. Connor et al., Effect of subchronic antidepressant treatments on behavioral, neurochemical, and endocrine changes in the forced-swim test, PHARM BIO B, 65(4), 2000, pp. 591-597
Citation: Jp. Kelly et S. Chang, Development of chromatic and luminance detection contours using the sweep VEP, VISION RES, 40(14), 2000, pp. 1887-1905
Authors:
Kelliher, P
Connor, TJ
Harkin, A
Sanchez, C
Kelly, JP
Leonard, BE
Citation: P. Kelliher et al., Varying responses to the rat forced-swim test under diurnal and nocturnal conditions, PHYSL BEHAV, 69(4-5), 2000, pp. 531-539